Birgitte Lausen
About
Birgitte Lausen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Birgitte Lausen has authored 84 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 50 papers in Public Health, Environmental and Occupational Health and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Birgitte Lausen's work include Acute Lymphoblastic Leukemia research (48 papers), Acute Myeloid Leukemia Research (43 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Birgitte Lausen is often cited by papers focused on Acute Lymphoblastic Leukemia research (48 papers), Acute Myeloid Leukemia Research (43 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Birgitte Lausen collaborates with scholars based in Denmark, Sweden and Norway. Birgitte Lausen's co-authors include Henrik Hasle, Kjeld Schmiegelow, Jonas Abrahamsson, Erik Forestier, Josefine Palle, Ólafur G. Jónsson, Bernward Zeller, Kirsi Jahnukainen, Jesper Heldrup and Sy Ha and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
In The Last Decade
Birgitte Lausen
80 papers receiving 1.7k citations
Peers
Birgitte Lausen
Katsuyoshi Koh Japan
Emmanuelle Tavernier France
Luca Lo Nigro Italy
Maria Caterina Putti Italy
Isabel Badell Spain
Ken Bradstock Australia
Kimikazu Matsumoto Japan
Françoise Mazingue France
Masamitsu Yanada Japan
A van der Does-van den Berg Netherlands
Citations per year, relative to Birgitte Lausen Birgitte Lausen (= 1×)
peers
Katsuyoshi Koh
Countries citing papers authored by Birgitte Lausen
Since
Specialization
Citations
This map shows the geographic impact of Birgitte Lausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitte Lausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitte Lausen more than expected).
Fields of papers citing papers by Birgitte Lausen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Birgitte Lausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitte Lausen. The network helps show where Birgitte Lausen may publish in the future.
Co-authorship network of co-authors of Birgitte Lausen
This figure shows the co-authorship network connecting the top 25 collaborators of Birgitte Lausen. A scholar is included among the top collaborators of Birgitte Lausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitte Lausen. Birgitte Lausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Castor, Anders, Hanne Vibeke Marquart, Birgitte Lausen, et al.. (2024). Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A‐rearranged acute leukemia. HemaSphere. 8(9). e70006–e70006.
2.
Tierens, Anne, Liv Osnes, Sanna Siitonen, et al.. (2024). Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1::RUNX1T1. Blood. 144(Supplement 1). 2954–2954.
3.
Tierens, Anne, Nira Arad‐Cohen, Daniel KL Cheuk, et al.. (2024). Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease. Journal of Clinical Oncology. 42(18). 2174–2185.
4.
Zeller, Bernward, Nira Arad‐Cohen, Daniel KL Cheuk, et al.. (2024). Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol. Haematologica. 109(9). 2873–2883.
5.
Andersson, Nadine G., et al.. (2023). Twenty years' experience of immune thrombocytopenia and intracranial haemorrhage in the Nordic countries—A NOPHO study. Acta Paediatrica. 112(5). 1097–1100.
6.
Cheuk, Daniel KL, Barbara De Moerloose, Henrik Hasle, et al.. (2023). Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia. British Journal of Haematology. 201(4). 757–765.
7.
Rouger, Jérémie, David Brossier, Meinolf Suttorp, et al.. (2022). Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course. Annals of Hematology. 102(3). 563–570.
8.
Palle, Josefine, Christofer Bäcklin, Jonas Abrahamsson, et al.. (2021). DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). Genes. 12(6). 895–895.
9.
Dziegiel, Morten Hanefeld, Grethe Risum Krog, Marianne Olsen, et al.. (2021). Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn. Transfusion Medicine and Hemotherapy. 48(5). 306–315.
10.
Güneş, Adalet Meral, Frédéric Millot, Krzysztof Kałwak, et al.. (2020). Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry. Pediatric Blood & Cancer. 68(1). e28706–e28706.
11.
Larsen, Hanne Bækgaard, et al.. (2020). Establishment of consensus on content and learning objectives for an interprofessional education in childhood cancer: a Delphi survey. BMJ Paediatrics Open. 4(1). e000634–e000634.
12.
Larsen, Hanne Bækgaard, Susanne Rosthøj, Jacob Nersting, et al.. (2020). Interprofessional versus monoprofessional case-based learning in childhood cancer and the effect on healthcare professionals’ knowledge and attitudes: study protocol for a randomised trial. BMC Health Services Research. 20(1). 1124–1124.
13.
Norén‐Nyström, Ulrika, Jonas Abrahamsson, Sy Ha, et al.. (2018). Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO‐AML) and review of the literature. Genes Chromosomes and Cancer. 57(7). 359–365.
14.
Millot, Frédéric, Joëlle Guilhot, Meinolf Suttorp, et al.. (2017). Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study). Blood. 130. 316–316.
15.
Söderhäll, S, Johan Arvidson, Erik Forestier, et al.. (2015). Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica. 101(1). 68–76.
16.
Gréen, Henrik, Ib Jarle Christensen, Kim Dalhoff, et al.. (2015). Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15(4). 372–379.
17.
Poulsen, Anja, et al.. (2013). [Visceral leishmaniasis in two children after vacation in Southern Europe].. PubMed. 175(38). 2193–4.
18.
Lausen, Birgitte, et al.. (2012). High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine. Pediatric Blood & Cancer. 60(7). 1154–1160.
19.
Frandsen, Thomas Leth, Jonas Abrahamsson, Birgitte Lausen, et al.. (2011). Individualized toxicity‐titrated 6‐mercaptopurine increments during high‐dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. British Journal of Haematology. 155(2). 244–247.
20.
Lausen, Birgitte, Kjeld Schmiegelow, Bente Utoft Andreassen, Hans O. Madsen, & Peter Garred. (2006). Infections during induction therapy of childhood acute lymphoblastic leukemia – no association to mannose‐binding lectin deficiency. European Journal Of Haematology. 76(6). 481–487.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Katsuyoshi Koh Breakdown of academic impact, for papers by Emmanuelle Tavernier Breakdown of academic impact, for papers by Luca Lo Nigro Breakdown of academic impact, for papers by Maria Caterina Putti Breakdown of academic impact, for papers by Isabel Badell Breakdown of academic impact, for papers by Ken Bradstock Breakdown of academic impact, for papers by Kimikazu Matsumoto Breakdown of academic impact, for papers by Françoise Mazingue Breakdown of academic impact, for papers by Masamitsu Yanada Breakdown of academic impact, for papers by A van der Does-van den Berg